Company Analysis

Palatin Technologies, Inc. (PTN)

Nasdaq: PTN · Pharmaceutical Preparations · Cranbury, NJ · filing with the SEC since 1996
Grade5.7
◀ Past 5.2● Present 6.0▶ Future 5.7
1 est.
The companyfiscal 2026, as filed
Revenue$8.8M
Net income-$8.4M+51.6%
Earnings per share$-2.96+90.8%
Operating cash flow-$13.5M+36.5%
Cash$7.5M+192.2%
Debtn/a
Shareholders’ equity$6.7M+240.0%
Shares, diluted2,827,233+425.2%
Return on equity-125.3%
The recordfrom its filings
Filings in 202622
Newest filingSep 28 · 10-K
Annual reportSep 28, 2026
Quarterly reportMay 13, 2026
Next report due10-Q by Nov 14
Insider sales, 12 months$0.00
Insider buys, 12 months$0.00
Patents granted92
Filer categoryNon-accelerated filer<br>Smaller reporting company
Trailing twelve months to Jun 2026Net income -$8.4MCash from operations -$13.5Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
17181920212223242526
As filed, in USD. Nothing here is a forecast.

News

Sep 28, 2026 · SEC EDGAR · Form 10-K
Annual report
Open the filing on sec.gov
Aug 5, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Aug 5, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Aug 5, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Aug 3, 2026 · SEC EDGAR · Form 8-K
Current report
Open the filing on sec.gov
Jul 17, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Jul 17, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Jun 25, 2026 · SEC EDGAR · Form DEF 14A
Proxy statement
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton PTN · research, not advice